Pharmaceutical PV DIV - FSB
Ended Indefinite Delivery Contract Awarded
- Contract number
- SPE2DB24D9801
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 183 $217,589 obligated
Award facts
- Opportunity
-
- SPM2DP13R0007 Solicitation number
- Combined order value
- $217,589 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $499,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is a single-award indefinite delivery contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, awarded on June 6, 2024, provides the DLA with a vehicle to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to meet the recurring medical supply needs of military health facilities worldwide. The contract, under the SPE2DB program, has an ultimate completion date of December 31, 2025.
Through this IDC, DMS Pharmaceutical Group provides the DLA and Department of Defense (DoD) with a diverse selection of medications, including branded and generic prescription drugs, over-the-counter medicines, biologics, and medical consumables across multiple therapeutic classes. The company's pharmaceutical offerings span common and specialized products, such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications for rare diseases. The contract enables the DLA to efficiently procure these essential pharmaceutical supplies to support the diverse medical requirements of military personnel and their dependents at DoD healthcare facilities globally.
Task orders
Show 40 more
Latest 50 of 183 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DB24D9801?
SPE2DB24D9801 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 6, 2024.
How much is contract SPE2DB24D9801 worth?
Orders under SPE2DB24D9801 have obligated $217,589. SPE2DB24D9801's own ceiling is $499,999,999.
How many orders have been placed under contract SPE2DB24D9801?
183 orders have been placed under SPE2DB24D9801, the latest on November 5, 2025.
Who can order from contract SPE2DB24D9801?
SPE2DB24D9801 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DB24D9801 competed?
The extent of competition for SPE2DB24D9801 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV